CompanySpainUpdated Apr 4, 2026
LifeLink Ventures

LifeLink Ventures

LifeLink Ventures: Investor • focus on Venture Capital, Impact • active in Europe, North America • offices in Spain.

Never miss breaking news

Get instant notifications when new news matching "LifeLink Ventures" are published.

Company Profile

LifeLink Ventures is an investment firm based in Barcelona, Spain, dedicated to bridging the gap between private capital and innovative investment opportunities in global health. The firm focuses on early-stage health and biotechnology companies that are developing urgently needed therapies to address significant global health challenges. They aim to provide private investors and family offices with direct access to exclusive life sciences investments, prioritizing both financial returns and a positive impact on human lives through biomedical innovation. LifeLink Ventures actively sources promising scientific and drug development ventures from its extensive network of research hubs and academic institutions across Europe, North America, and beyond.

Founded in 2020, LifeLink Ventures was established by a team with diverse and extensive experience at the intersection of biotech innovation and capital markets. Key partners include Francisca Peixoto, who brings over eight years of R&D experience from top institutions and an Executive MBA, and previously served as Chief Science Officer at WEcubed Partners. Leo Figueiredo, a Brazilian financial market entrepreneur, provides strategic guidance with a background in developing capital markets and fund management businesses, including Hedging-Griffo. Ricardo Salomao, a medical doctor specializing in musculoskeletal radiology, has a strong executive background in healthcare and a history of over 25 investments in the health sector in Brazil and Mexico.

The firm's portfolio reflects its commitment to groundbreaking health and biotech companies. Notable investments and portfolio companies mentioned include Eveliqure, HAYA Therapeutics, AIRNA, Accure Therapeutics, Arda Therapeutics, Spiral Therapeutics, Ochre Bio, InCephalo, and Macomics. These companies are often involved in developing novel therapies, vaccines, and other biomedical innovations. LifeLink Ventures has participated in various funding rounds, including Series A and Seed rounds, demonstrating its focus on supporting companies from their early stages of development.

The LifeLink Ventures team comprises professionals with deep scientific and financial expertise. Beyond the founding partners, the team includes associates and analysts such such as Ana Duran, Pablo Heredia, Pablo Ventós, and Alba Schmahl, who contribute to scientific due diligence and project analysis. Thiago Figueiredo serves as an advisor, and Afonso Sá handles back-office operations. This collective expertise allows the firm to conduct rigorous, data-driven due diligence processes, grounded in in-house scientific knowledge and insights from key opinion leaders in specific fields, ensuring that investments are made in talented entrepreneurs with high-quality data and a clear vision.

News & Signals (0)

No linked news activity found for this company.

Investor Listings

Similar Companies

Ranked by shared taxonomies: sector, subsector, geography, asset class and investor lists.

No similar companies found with overlapping taxonomy tags.